# THE CATALYTIC IMPACT FOUNDATION (CIF)

> THE CATALYTIC IMPACT FOUNDATION (CIF) is a VC fund backing Health Care. See 54 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 54
- Last investment: Mar 2026
- Lead investor: 4%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/catalyticimpactfoundation/
- Website: http://www.cifimpact.org

THE CATALYTIC IMPACT FOUNDATION (CIF) is a VC fund in New York focused on Health Care and Biotechnology. The Catalytic Impact Foundation accelerates breakthroughs — championing extraordinary innovations, catalytic ideas, and, most importantly, visionary leaders. The Foundation aims to solve complex problems and accelerate innovations, alleviate human suffering, address inequities, and improve the quality of human life through disruptive and scalableprojects in the life sciences, education, inclusive entrepreneurship and global sustainability. The Foundation is a registered 501(c)(3) charitable organization incorporated in New York State.

## Contacts

5 contacts available for THE CATALYTIC IMPACT FOUNDATION (CIF). Shizune tracks 3 team members at THE CATALYTIC IMPACT FOUNDATION (CIF). Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/the-catalytic-impact-foundation-cif?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 28 | 52% |
| Biotechnology | 27 | 50% |
| Medical | 13 | 24% |
| Therapeutics | 10 | 19% |
| Pharmaceutical | 7 | 13% |

45 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 15 | 28% |
| Funding Round | 8 | 15% |
| Seed | 7 | 13% |
| Series A | 7 | 13% |
| Series B | 7 | 13% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 42 | 78% |
| India | 1 | 2% |
| Australia | 1 | 2% |
| United Kingdom | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Rachel Butler | President | 1 | https://shizune.co/investors/profile/rachel-ross-butler |
| Richard Lipkin | Co- Founder, Co-Chair | 0 | https://shizune.co/investors/profile/richard-lipkin |
| Robert Wolk | Executive Board Chair | 0 | https://shizune.co/investors/profile/robert-wolk-6769 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Flourish Care | FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey. | $5.7M | Seed | Mar 18, 2026 |  |
| Egal Pads | Egal is a manufacturer of pads on a roll, a product that can be dispensed in every public stall as easily as toilet paper. | $4M | Series A | Jan 22, 2025 |  |
| National Renewable Network | The National Renewable Network is a linked network of solar and storage systems that transforms the way energy is supplied. | $6.6M | Venture - Series Unknown | Jan 17, 2024 |  |
| Bicara Therapeutics | Bicara Therapeutics, a wholly-owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. which accelerates the development of cutting-edge therapies for cancer. Synergies between thescientific teams in Boston and Bengaluru will pioneer rapid and cost-effective breakthrough innovation. | $165M | Series C | Dec 12, 2023 |  |
| Rejuvenation Technologies | Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California. |  |  | Oct 11, 2023 |  |
| Wavely Diagnostics | Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care. | $1.4M | Seed | Jul 12, 2023 |  |
| Bicara Therapeutics | Bicara Therapeutics, a wholly-owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. which accelerates the development of cutting-edge therapies for cancer. Synergies between thescientific teams in Boston and Bengaluru will pioneer rapid and cost-effective breakthrough innovation. | $108M | Series B | Mar 06, 2023 |  |
| Ceretype Neuromedicine | Ceretype Neuromedicine is an AI-based fMRI brain biomarker technology to improve drug discovery and patient care. Based in Cambridge Massachusetts, Ceretype is founded on seminal scientific discoveries made in the laboratory of Emily Stern, David Silbersweig, and Hong Pan at Brigham and Women’s Hospital/Harvard Medical School (BWH/HMS). | $100K | Pre-Seed | Mar 02, 2023 |  |
| Alto Neuroscience | Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. | $25M | Series B | Jan 30, 2023 |  |
| OffScrip Health | Healthcare is too complex. We're here to make it simple. |  | Venture - Series Unknown | Jan 01, 2023 |  |

10 of 54 investments shown.

## Co-investors
- [Invus](https://shizune.co/investors/profile/invus) — VC Fund, 3 deals together
- [Piper Heartland Healthcare Capital](https://shizune.co/investors/profile/piper-heartland-healthcare-capital) — VC Fund, 3 deals together
- [Bioqube Ventures](https://shizune.co/investors/profile/bioqube-ventures) — VC Fund, 2 deals together
- [Eight Roads Ventures](https://shizune.co/investors/profile/eight-roads-ventures) — VC Fund, 2 deals together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 2 deals together
- [Hibiscus BioVentures](https://shizune.co/investors/profile/hibiscus-bioventures) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Renewable Energy Investors in Oceania](https://shizune.co/investors/renewable-energy-investors-oceania)
- [Sustainability Investors in Australia](https://shizune.co/investors/sustainability-investors-australia)
- [Impact Investors in Australia](https://shizune.co/investors/impact-investors-australia)
- [Sustainability VC Funds in Australia](https://shizune.co/investors/sustainability-vc-funds-australia)
- [Impact VC Funds in Australia](https://shizune.co/investors/impact-vc-funds-australia)

## FAQ

### What does THE CATALYTIC IMPACT FOUNDATION (CIF) invest in?

THE CATALYTIC IMPACT FOUNDATION (CIF) invests primarily in Health Care, Biotechnology and Medical startups, most often at Venture - Series Unknown and Funding Round stage. Most of the 54 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact THE CATALYTIC IMPACT FOUNDATION (CIF)?

Public channels for THE CATALYTIC IMPACT FOUNDATION (CIF) include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at THE CATALYTIC IMPACT FOUNDATION (CIF)?

The team at THE CATALYTIC IMPACT FOUNDATION (CIF) includes Rachel Butler (President), Richard Lipkin (Co- Founder, Co-Chair) and Robert Wolk (Executive Board Chair). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co